A destiny to fulfill

Same author

Survivin targeting triple-fusion vaccine <sub>DC</sub>Survivin-LTB inhibits tumor growth in mouse model of triple-negative breast cancer.

Medical oncology (Northwood, London, England)·2025

Same author

Expression, purification and characterization of a novel triple fusion protein developed for the immunotherapy of survivin positive cancers.

Protein expression and purification·2024

Same author

Humanized recombinant immunotoxin targeting hCG demonstrates therapeutic potential for advanced stage difficult to treat cancers.

Journal of drug targeting·2024

Same author

Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model.

World journal of clinical oncology·2019

Same author

Immunotherapy approach with recombinant survivin adjuvanted with alum and MIP suppresses tumor growth in murine model of breast cancer.

Preparative biochemistry & biotechnology·2018

Same author

Development of a novel recombinant LHRH fusion protein for therapy of androgen and estrogen dependent cancers.

Protein expression and purification·2017

Same journal

Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment.

Journal of biosciences·2026

Same journal

Evolutionary trade-offs in plant immunity: prioritizing antiviral priming by herbivore-induced plant volatiles over defense against herbivores.

Journal of biosciences·2026

Same journal

Birds and bees do not express RAGE: comparative physiology and non-conventional model organisms hold the key to hyperglycemia tolerance.

Journal of biosciences·2026

Same journal

Distinct macrophage and microglia function in ischemic stroke.

Journal of biosciences·2026

Same journal

Dynamic attributes of the pedicel: Key drivers, structure and function in angiosperms.

Journal of biosciences·2026

Same journal

Cardiometabolomic signatures and gut microbiota dynamics in perinatally undernourished F<sub>1</sub> offspring: Decoding the metabolic footprint.

Journal of biosciences·2026

Related Experiment Videos

A destiny to fulfill

Related Concept Videos

Survivin targeting triple-fusion vaccine <sub>DC</sub>Survivin-LTB inhibits tumor growth in mouse model of triple-negative breast cancer.

Expression, purification and characterization of a novel triple fusion protein developed for the immunotherapy of survivin positive cancers.

Humanized recombinant immunotoxin targeting hCG demonstrates therapeutic potential for advanced stage difficult to treat cancers.

Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model.

Immunotherapy approach with recombinant survivin adjuvanted with alum and MIP suppresses tumor growth in murine model of breast cancer.

Development of a novel recombinant LHRH fusion protein for therapy of androgen and estrogen dependent cancers.

Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment.

Evolutionary trade-offs in plant immunity: prioritizing antiviral priming by herbivore-induced plant volatiles over defense against herbivores.

Birds and bees do not express RAGE: comparative physiology and non-conventional model organisms hold the key to hyperglycemia tolerance.

Distinct macrophage and microglia function in ischemic stroke.

Dynamic attributes of the pedicel: Key drivers, structure and function in angiosperms.

Cardiometabolomic signatures and gut microbiota dynamics in perinatally undernourished F<sub>1</sub> offspring: Decoding the metabolic footprint.

Related Experiment Videos

A destiny to fulfill

Related Concept Videos

Related Articles

Survivin targeting triple-fusion vaccine <sub>DC</sub>Survivin-LTB inhibits tumor growth in mouse model of triple-negative breast cancer.

Expression, purification and characterization of a novel triple fusion protein developed for the immunotherapy of survivin positive cancers.

Humanized recombinant immunotoxin targeting hCG demonstrates therapeutic potential for advanced stage difficult to treat cancers.

Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model.

Immunotherapy approach with recombinant survivin adjuvanted with alum and MIP suppresses tumor growth in murine model of breast cancer.

Development of a novel recombinant LHRH fusion protein for therapy of androgen and estrogen dependent cancers.

Hypercholesterolemia-induced impairment in sorafenib functionality is overcome by avasimibe co-treatment.

Evolutionary trade-offs in plant immunity: prioritizing antiviral priming by herbivore-induced plant volatiles over defense against herbivores.

Birds and bees do not express RAGE: comparative physiology and non-conventional model organisms hold the key to hyperglycemia tolerance.

Distinct macrophage and microglia function in ischemic stroke.

Dynamic attributes of the pedicel: Key drivers, structure and function in angiosperms.

Cardiometabolomic signatures and gut microbiota dynamics in perinatally undernourished F<sub>1</sub> offspring: Decoding the metabolic footprint.